Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Mesalamine for Colorectal Cancer Prevention Program in Lynch SyndromeColorectal Neoplasms, Hereditary Nonpolyposis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Digestive System Diseases, Digestive System Neoplasms, Lynch syndrome, Neoplasms by Site, Nutritional and Metabolic Diseases, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, malignant colon neoplasm, metabolic disease, neoplasmRecruitingPhase 22024-12-17NCT04920149

3 results · Page 1 of 1

Swipe the table sideways for more columns.

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aalborg University HospitalAalborgDenmark54
Akademiska hospitalUppsalaSweden2
Ersta Hospital/Ersta DiakoniStockholmSweden1
Hvidovre HospitalHvidovreDenmark27
Karolinska University HospitalStockholmSweden15
Norrland University HospitalUmeåSweden1
Sahlgrenska University HsospitalGothenburgSweden1
Skåne University HospitalMalmöSweden2